Liver Transplantation in Two Children with Tyrosinaemia Type I: Biochemical Aspects

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 1991 Jan 1

PMID 1770775

Citations 2

Authors

E Riudor

A Ribes

J Lloret

J Friden

E Holme

C Jakobs

V Martinez Ibanez

Affiliations

Soon will be listed here.

Citing Articles

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1.

van Ginkel W, Rodenburg I, Harding C, Hollak C, Heiner-Fokkema M, van Spronsen F Paediatr Drugs. 2019; 21(6):413-426.

PMID: 31667718 PMC: 6885500. DOI: 10.1007/s40272-019-00364-4.

Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Grompe M, Overturf K, Finegold M J Inherit Metab Dis. 1998; 21(5):518-31.

PMID: 9728332 DOI: 10.1023/a:1005462804271.

References

Starzl T, Zitelli B, Shaw Jr B, Iwatsuki S, Gartner J, Gordon R . Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr. 1985; 106(4):604-6. PMC: 2964149. DOI: 10.1016/s0022-3476(85)80081-0. View

Tuchman M, Whitley C, Ramnaraine M, Bowers L, Fregien K, Krivit W . Determination of urinary succinylacetone by capillary gas chromatography. J Chromatogr Sci. 1984; 22(5):211-5. DOI: 10.1093/chromsci/22.5.211. View

Holme E, Lindblad B, Lindstedt S . Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia. Lancet. 1985; 1(8427):527. DOI: 10.1016/s0140-6736(85)92132-4. View

Tsai S, Huang G, Yang P, Sheu J, SUNG J, Chen D . Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology. 1990; 11(3):481-8. DOI: 10.1002/hep.1840110321. View

TSCHUDY D, Hess R, Frykholm B . Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid. J Biol Chem. 1981; 256(19):9915-23. View